Normalised provider profile

Dynamic42 develops microfluidic organ models for biomedical research. Organs-on-chip can study compounds and disease mechanisms in defined experimental systems. Laboratories should assess cell sources, reproducibility, measurement methods, throughput and validation for their question. A collaboration is not general evidence of clinical efficacy. Cell models target specific biological questions. Results need controls and independent methods before informing development decisions.